Par Steps In With Chantix Rival After Pfizer Recall
Endo Unit’s Launch Of US Varenicline Tablets Comes After Early Approval
Endo’s Par generics unit has launched the first US generic version of Pfizer’s Chantix (varenicline) tablets, entering the market just after the originator recalled the brand over nitrosamine impurities.
